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The introduction of laparoscopic cholecystectomy was associated with increased incidences of bile duct injury.
The primary cause appears to be misidentification of the biliary anatomy. Routine intra-operative cholangiography
has been recommended to reduce accidental duct injury, although in practice it is more often reserved for selected
cases. There has been interest in the use of fluorescent agents excreted via the biliary system to enable real-time
intra-operative imaging, to aid the laparoscopic surgeon in correctly interpreting the anatomy. The primary aim
of this review is to evaluate the ability of fluorescent cholangiography to identify important biliary anatomy
intra-operatively. Secondary aims are to investigate its ability to detect important intra-operative pathology such
as bile leaks, identify potential alternative fluorophores, and evaluate the evidence regarding patient outcomes.
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FluorophoreIntroduction
Misidentification of the biliary anatomy has been cited
as the commonest cause of bile duct injury during
laparoscopic cholecystectomy [1]. Although this com-
plication is infrequent [2], affected patients suffer con-
siderably [3]. Therefore attempts to further reduce its
incidence are justifiable. Intra-operative cholangiography
has been recommended to reduce bile duct injuries,
although in practice it is often reserved for selected
cases [4]. Fluorescent cholangiography (FC) is a novel
technique which offers real-time intra-operative imaging
of the biliary anatomy. The primary aim of this review is
to evaluate the ability of FC to identify important biliary
anatomy intra-operatively. Secondary aims are to inves-
tigate its ability to detect important intra-operative pa-
thology such as bile leaks, identify potential alternative
fluorophores, and evaluate the evidence regarding pa-
tient outcomes.
The first intra-operative use of FC in humans was de-
scribed by Ishizawa et al. [5]. The method involved the
administration of indocyanine green (ICG) by either
intra-biliary injection, or intravenous injection before* Correspondence: darrenscroggie@yahoo.co.uk
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article, unless otherwise stated.surgery. ICG binds to proteins present in bile, and is
excreted exclusively by the liver when administered
intravenously. The excitation of protein-bound ICG by
near-infrared light causes it to fluoresce, thereby delin-
eating components of the biliary system to the surgeon.
This is accomplished by the use of a specialised camera
system, which illuminates the target with near-infrared
light and filters the reflected wavelengths, such that the
fluorescing ICG is clearly observed. The principle of FC
is illustrated in Figure 1.
Intra-operative FC has been successfully performed
during laparoscopic cholecystectomy in several studies
[6-14]. These include standard multiple-incision, single-
incision and robot-assisted single-incision operations.
The technique is not limited to use during laparoscopic
cholecystectomy only; its feasibility and utility during
hepatectomies for tumours and living donor liver trans-
plantation have also been described [15]. It has been
used in sentinel lymph node mapping during breast can-
cer surgery, prior to its adoption for FC [16].
Various devices have been described for use in FC.
They represent different physical realisations of the same
basic principles. Common to all these devices is the in-
clusion of an excitation light source to cause fluores-
cence, and a charge coupled device (CCD) with filtering
to capture the fluorescent image. A method of switchingCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Principle of fluorescent cholangiography. A source of
near-infrared light (A) emits an excitation wave (B), which is directed
towards the fluorophore-filled biliary tree at (C). The fluorophore,
shown bound to a protein, is excited (D), causing emission of a longer
wavelength (E). A filter (F) removes unwanted shorter wavelengths. An
image of the fluorescing biliary tree is formed on the charge-coupled
device (G), which is then processed for viewing by suitable electronics.
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mode is provided in the case of laparoscopic cameras.
Differences exist in the physical forms of the devices, the
excitation wavelength, the emission filter, and the image
capture characteristics of the CCD. The device used by
Ishizawa et al. [5] during open cholecystectomies and
liver resections was a hand-held unit with a separate
control unit. Light-emitting diodes produced near-infra-
red excitation at 760 nm, and the image was captured by
the CCD camera after filtering out wavelengths shorter
than 820 nm. The fluorescence was detectable by the
CCD as excited ICG emits a longer wavelength of about
830 nm. This was viewable both by the naked eye and
on a television monitor with the operating lights off.
This device was intended for open surgery, and was
not suitable for laparoscopic use. A different deviceTable 1 Detection rates of biliary structures using fluorescent
Study Technique N CD
Ishizawa et al. (2010) [12] LC 52 52 (10
Aoki et al. (2010) [19] LC 14 10 (71
Ishizawa et al. (2011) [6] SILC 7 5 (71.4
Kaneko et al. (2012) [8] LC 28 26 (92
Buchs et al. (2012) [7] SIRC 12 11 (91
Schols et al. (2013) [9] LC 15 15 (10
Spinoglio et al. (2013) [10] SIRC 45 42 (93
LC, standard laparoscopic cholecystectomy.
SILC, single-incision laparoscopic cholecystectomy.
SIRC, single-incision robotic cholecystectomy.
N, number of patients in study.
-, data not reported.developed for sentinel lymph node mapping in breast
cancer surgery [17] has been successfully used during
open hepatobiliary surgery [14].
Ishizawa et al. later report successfully performing
ICG FC during laparoscopic cholecystectomy, using a
different prototype device [18]. The described instru-
ment comprised a xenon light source, a small control
unit, and a laparoscope with CCD camera filtering wave-
lengths below 810 nm. A foot switch allowed the
surgeon to alternate between standard and fluorescent
images. The practicality of the same or similar systems
in laparoscopic cholecystectomy has been verified in se-
veral other studies; a device for use with the da Vinci
robot is also available, and robot-assisted laparoscopic
cholecystectomy with ICG fluorescent cholangiography
has been performed in many patients [7,10,11].
Review
Identification of biliary structures
The first human study of intra-operative FC in open sur-
gery reported the successful identification of several im-
portant biliary structures [5]. Intra-biliary injection of
ICG allowed identification of the common hepatic duct
(CHD) and confluence of the right and left hepatic ducts
in 100% of patients (n = 13) undergoing hepatectomy.
Intravenous administration in patients (n = 10) undergo-
ing open cholecystectomy revealed the CHD in 100%,
and the cystic duct (CD) in 90%. Visualisation of the
common bile duct (CBD) is not reported in this study.
The use of the laparoscopic system also appears to
effectively delineate extrahepatic ducts. The structures
successfully identified before dissection of Calot’s trian-
gle include the CD, CHD, CBD, and the junction of the
CD with the CHD [6-10,12,19]. These include standard,
single-incision and robotic procedures. Table 1 sum-
marises the published detection rates of major biliary
structures before dissection of Calot’s triangle. Overall,
the preliminary studies suggest the technique is effectivecholangiography
CHD CD/CHD junction CBD
0%) 50 (96.2%) 50 (96.2%) -
.4%) - - 10 (71.4%)
%) 7 (100%) 7 (100%) -
.9%) 27 (96.4%) - -
.6%) 4 (33.3%) 3 (25%) 6 (50%)
0%) - - 15 (100%)
%) 40 (80%) 40 (80%) 41 (91%)
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nificant differences in technique and methodology exist
between studies; therefore it is difficult to accurately
quantify overall rates of detection. Furthermore, it is not
apparent whether or not the surgeon could have identi-
fied the same structures unaided.
The literature contains some reports of FC identifying
anatomical variants of the biliary tree. In a study of open
surgery, it effectively identified right lateral sector bran-
ches draining into the CHD [5]. A study of the laparo-
scopic technique demonstrated a sensitivity of 100% for
detecting accessory hepatic ducts in 8 patients, after dis-
section of Calot’s triangle [12]. In these patients, such
variants had already been identified during pre-operative
investigations. A parallel course of the CD and CHD was
identified in one laparoscopic study using FC [9]. There
are no reports of detection of anatomical variants during
robotic cholecystectomy. As yet, there are no studies to
determine the sensitivity of FC in detecting anatomical
variants whose existences are not already known from
prior investigations.
An extension of the fluorescence technique has been
described to enable intra-operative fluorescent angiog-
raphy alongside cholangiography, for the purpose of iden-
tifying the cystic artery [8,13]. The technique involves a
pre-operative intravenous injection of ICG to facilitate FC,
with a second ICG bolus administered intra-operatively to
enable identification of the cystic artery. In the larger of
the studies, the cystic artery began to fluoresce at 20 to
30 seconds after the bolus, and was identified successfully
in 25 of 28 patients (89.3%) [8]. Fluorescence of the artery
lasted for over 5 to 10 seconds. The authors suggest this
ICG re-injection technique may facilitate safer dissection
of the cystic artery, especially in difficult cases.
FC has several specific limitations described. The major
one is its inability to visualise deep intrahepatic ducts, or
extrahepatic ducts covered with surrounding organs and
tissue, due to the limited tissue penetration of near-
infrared light [5]. It can be unusable in obese patients [19].
Calot’s triangle needs to be adequately exposed to obtain
good fluorescent images, which can disadvantage the inex-
perienced laparoscopic surgeon [12]. A simple transparent
plastic compression device has been described to help
overcome these problems, which can reduce the thickness
of extramural tissue and facilitate a clearer view [13].
The other limitations are less clear due to lack of good
quality supporting evidence. Its ability to detect biliary
stones, bile leaks and bile duct injuries in humans is not
known. No reports investigate user dependence. It is
not clear if FC affects the operative time, although a
recent study of its use during robotic laparoscopic
cholecystectomy found no statistically significant dif-
ference compared to standard robotic laparoscopic
cholecystectomy [11]. If it is to be pursued for thesevarious applications, more research in large animals or
humans is required.
Detection of bile leaks
The ability of FC to detect intra-operative bile leaks has
been investigated to a limited extent. Studies in mouse
models have shown that leaks were more apparent on
fluorescent images than on standard imaging [20,21].
Bile leaks were readily identified even without a fluoro-
phore, due to the autofluorescence of bile [21]. Tagaya
et al. observed that bile leakage caused by cannulation
of the cystic duct in humans for IOC was easily visua-
lised on fluorescent imaging [13]. However, detection of
previously unknown bile leaks has not been reported.
Detection of biliary stones
An important application of standard fluoroscopic intra-
operative cholangiography (IOC) is the detection of biliary
stones. It has been shown in mouse models that simulated
CBD stones can be imaged using fluorescence of VM674
[21]. There is no evidence that FC can effectively identify
CBD stones in humans. Most of the human studies lack
patients with CBD stones. One study describes a failure to
identify a CBD stone in one patient which had previously
been identified during pre-operative investigations, al-
though CD stones were identified in some patients [12].
The ability of the technique to detect stones elsewhere in
the biliary tree, such as the CHD, has not been investi-
gated. Indeed, the intra-hepatic ducts and those covered
by thick tissue are inaccessible [5]. Thus the available
evidence does not suggest that FC is likely to replace
standard intra-operative cholangiography in cases where
biliary stones are suspected.
Fluorophores
ICG is the only agent that is reported to have been used in
humans for the purpose of FC. There has been a con-
trolled trial in mouse models of VM674, a fluorophore
designed and developed for rapid biliary excretion after
intravenous administration [21]. This study demonstrated
rapid and sustained visualisation of the biliary anatomy,
and image target-to-background ratios favouring VM674
over ICG. However, proponents of ICG argue that the
VM674 technique may not work so well in humans; the
shorter wavelengths of light used for VM674 have poorer
tissue penetration, and the connective tissue around the
biliary system in humans is much thicker compared to
that of the mouse [22]. The pharmacokinetic properties of
VM674, particularly rapid and high biliary excretion, may
make it more suitable for imaging acute biliary injuries or
leaks that develop intra-operatively, as ICG needs to be
administered well in advance [23].
Other fluorophores have been investigated in rats and
pigs, notably an ICG-related molecule called CW800-CA
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ICG [24]. ICG remains the only fluorophore to be used in
humans due to its established safety and availability, al-
though the animal studies suggest it may not necessarily
be the most efficient. It has also been demonstrated in
mice that FC can be performed without the aid of a fluo-
rophore; bile will autofluoresce when excited by light at
475 nanometres, sufficiently intensely as to render a real-
time cholangiogram [20].
The equipment used for non-ICG fluorophores differs
in the wavelengths of light involved. For VM674, an exci-
tation wavelength of 649 nm is used, producing fluores-
cence at 675 nm [21]. In the autofluorescence technique,
the excitation is 475 nm, producing emissions at 480 nm
[20]. Both of these experimental studies involved mouse
models, using appropriate equipment. These techniques
have not been applied to humans, and no suitable equip-
ment is described.
The timing of administration of the fluorophore merits
consideration. ICG injected into the bile duct is admi-
nistered intra-operatively, whereas intravenous ICG is
administered pre-operatively [5]. There is a delay from
intravenous injection until the extrahepatic ducts become
visible by fluorescence. This time interval has been quanti-
fied at 90 minutes in pig models [25]. Studies in humans
report satisfactory results with administration 30 minutes
or one hour before surgery, with fluorescence lasting at
least until closure of the abdominal incisions [19]. A
recent study investigating the dose and timing of ICG ad-
ministration found that a prolonged interval of 24 hours
between administration and surgery produced optimal
contrast of the CBD against the liver, compared to admin-
istration 30 minutes before surgery [14]. The improved
contrast was due to a lower liver background signal. How-
ever, intervals between the two extremes were not in-
vestigated. Furthermore, the excretion of intravenously
administered ICG is impaired by hepatic dysfunction [26].
The alternative fluorophore VM674 is more rapidly ex-
creted in bile, and the extrahepatic ducts in mouse models
can be identified by fluorescence between 2 and 5 minutes
after intravenous injection, with a fluorescence peak at
25 minutes [21]. However, this property of VM674 has
not been investigated in humans. Therefore, there is a
requirement for more research to determine the optimal
administration protocols for the fluorophore.
The effect of the fluorophore dose has been investi-
gated in humans using ICG [14]. It appears from this
study that larger doses of ICG cause more fluorescence
of the liver, which reduces the signal-to-background ra-
tio of the bile ducts. Since both the ICG dose and time
interval from administration to surgery affected the
signal-to-background ratio, the optimum dose needs to
be matched to this time interval. Unfortunately the study
only investigates doses of 5 mg, 10 mg and 20 mg, andtime intervals of 30 minutes and 24 hours. The optimal
dose and time may lie between these values.
Patient outcomes
Whilst FC may afford the surgeon the ability to more
readily define the extrahepatic biliary anatomy, it is of
more importance to consider its effect on the patient.
Firstly, it is logical to consider the effect of the fluorophore
itself on the patient. ICG is already in routine clinical use
and is considered generally safe, but adverse reactions
have been reported. A review by Benya et al. described the
various reactions that have been reported [27]. In this
group of patients, urticaria, sensations of warmth and
headache were common. Dyspnoea and wheezing are also
reported, and one patient died due to laryngospasm.
Other reactions include sore throat, nausea, pruritis,
peripheral vasodilatation with hypotension, tachycardia,
pulmonary congestion, and oedema, although overall reac-
tions are rare [28]. Therefore concerns of adverse reac-
tions are not sufficient to preclude the use of ICG in
routine laparoscopic cholecystectomy.
It is not yet clear whether improved visualisation of
the extrahepatic biliary anatomy by FC actually trans-
lates into improved patient outcomes. Although no bile
duct injuries have been reported when using FC, the
sample sizes are small and the studies may be inad-
equately powered to detect rare outcomes. The largest
study of FC in laparoscopic cholecystectomy enrolled 52
patients [12]. The median post-operative hospital stay
was 5 days, and no postoperative bile leaks occurred. It
is not apparent why the hospital stays reported in this
study are considerably longer than those reported in
other studies of laparoscopic cholecystectomy. A recent
trial of laparoscopic cholecystectomy using different
numbers of incisions describes a mean post-operative
hospital stay of only 1.2 days for a 4-port technique [29].
There is similarly a lack of data on longer term out-
comes, as the available studies focus primarily on the
intra-operative period, with brief mentions of the early
post-operative period. It is necessary to investigate the
need for re-admission and re-operation after discharge,
in order to determine whether FC has any beneficial in-
fluence on these longer-term outcomes.
Conclusion
FC is a novel imaging technique which has been shown to
effectively illuminate the extrahepatic biliary anatomy dur-
ing laparoscopic surgery, producing impressive detection
rates for the more important structures. The most exten-
sively used fluorophore, ICG, is already clinically available.
To date, human studies of FC in laparoscopic cholecystec-
tomy have demonstrated its feasibility and apparent safety.
It is unlikely to replace fluoroscopic IOC in cases where
biliary stones are suspected, and there is insufficient
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verse events associated with laparoscopic cholecystec-
tomy. Nevertheless its relative simplicity may justify its
use if it can be shown to reduce bile duct injuries. Further
research should aim to quantify the effects of this tech-
nique on adverse events and long-term patient outcomes.
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